Brexit: Growing differences between drugs approved for GB and NI, says report
Post-Brexit divergence between NI and the rest of the UK on drugs is increasing, research suggests. …
“This includes utilisation of the Northern Ireland MHRA Authorised Route (NIMAR), which has been designed to ensure that people in Northern Ireland can continue to access medicines should clinical need be unable to be met through authorised products or any other regulatory routes,” the spokesperson added.
About The Author
